ARA 290 vs Oxytocin
Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of ARA 290 and Oxytocin (also searched as Oxytocin vs ARA 290) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
ARA 290 centers on neuro, while Oxytocin leans toward neuro. On indexed research, Oxytocin is ahead (ARA 290: 33 studies, Human evidence; Oxytocin: 34, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •ARA 290 is strongest for neuro; Oxytocin for neuro.
- •Evidence: ARA 290 Human evidence (33 studies) vs Oxytocin Human clinical (34).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
ARA 290 vs Oxytocin: side-by-side
| Metric | ARA 290 | Oxytocin |
|---|---|---|
| Class | Neuro | Neuro |
| Regulatory status | Research use only | FDA-approved |
| Evidence grade | Human evidence | Human clinical |
| Studies indexed | 33 | 34 |
| Research level | Preclinical | FDA Approved |
| Strongest effect | Neuro & mood | Neuro & mood |
| Healing & recovery | 4.0▲ | 3.0 |
| Muscle & body comp | 0.0 | 0.0 |
| Metabolic & appetite | 2.0▲ | 0.0 |
| Neuro & mood | 5.0▲ | 4.0 |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 3.0▲ | 0.0 |
| Skin & aesthetics | 0.0 | 0.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | ARA 290 | Oxytocin |
|---|---|---|
| Mechanism | Modulates macrophage activity and promotes anti-inflammatory cytokine release | Oxytocin receptor agonist |
| Route | Subcutaneous injection | Intravenous injection, intranasal administration |
| Half-life | — | ~3–5 min |
| Time to peak | — | ~30 min |
| Duration of action | — | ~2–4 hours |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is ARA 290?
ARA 290, also known as a peptide derived from the erythropoietin (EPO) molecule, has garnered attention for its potential therapeutic applications, particularly in the context of nerve regeneration and protection. The peptide is designed to mimic some of the beneficial effects of EPO without eliciting the same erythropoietic activity, which can lead to unwanted side effects such as increased blood viscosity and hypertension.
Full ARA 290 profile, mechanism & studies →What is Oxytocin?
Oxytocin is a neuropeptide that plays a crucial role in social bonding, reproductive behaviors, and emotional regulation. Its functions extend to various physiological processes, including childbirth and lactation, and it has garnered interest for its potential therapeutic applications in mental health and social disorders.
Full Oxytocin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | ARA 290 | 4.0/5 effect signal |
| Metabolic | ARA 290 | 2.0/5 effect signal |
| Neuro | ARA 290 | 5.0/5 effect signal |
| Inflammation | ARA 290 | 3.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack ARA 290 and Oxytocin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
ARA 290 vs Oxytocin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
ARA 290 has 33 approved studies indexed (Human evidence), and Oxytocin has 34 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is ARA 290 or Oxytocin better?
It depends on your goal. ARA 290 is strongest for neuro; Oxytocin for neuro. Oxytocin has more indexed studies (34). See the goal-by-goal breakdown above.
Is ARA 290 or Oxytocin better for weight loss?
ARA 290 shows the stronger metabolic & appetite profile (2.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Which has more research, ARA 290 or Oxytocin?
ARA 290 has 33 approved studies indexed (Human evidence); Oxytocin has 34 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack ARA 290 and Oxytocin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of ARA 290 vs Oxytocin?
ARA 290: no community-reported effects logged yet. Oxytocin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is ARA 290 or Oxytocin FDA-approved?
ARA 290 is a research-use compound and is not FDA-approved. Oxytocin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Oxytocin better than ARA 290?
For neuro, Oxytocin has the edge; for neuro, ARA 290 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.